GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » E10

DaShenLin Pharmaceutical Group Co (SHSE:603233) E10 : ¥0.83 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

DaShenLin Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.170. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.83 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-06), DaShenLin Pharmaceutical Group Co's current stock price is ¥16.76. DaShenLin Pharmaceutical Group Co's E10 for the quarter that ended in Sep. 2024 was ¥0.83. DaShenLin Pharmaceutical Group Co's Shiller PE Ratio of today is 20.19.

During the past 12 years, the highest Shiller PE Ratio of DaShenLin Pharmaceutical Group Co was 20.28. The lowest was 16.39. And the median was 18.43.


DaShenLin Pharmaceutical Group Co E10 Historical Data

The historical data trend for DaShenLin Pharmaceutical Group Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaShenLin Pharmaceutical Group Co E10 Chart

DaShenLin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

DaShenLin Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.83

Competitive Comparison of DaShenLin Pharmaceutical Group Co's E10

For the Biotechnology subindustry, DaShenLin Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaShenLin Pharmaceutical Group Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where DaShenLin Pharmaceutical Group Co's Shiller PE Ratio falls into.


;
;

DaShenLin Pharmaceutical Group Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DaShenLin Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.17/115.7848*115.7848
=0.170

Current CPI (Sep. 2024) = 115.7848.

DaShenLin Pharmaceutical Group Co Quarterly Data

per share eps CPI Adj_EPS
201212 0.000 95.237 0.000
201312 -0.450 97.624 -0.534
201412 0.000 99.000 0.000
201506 0.670 99.500 0.780
201512 0.560 100.600 0.645
201603 0.119 102.200 0.135
201606 0.106 101.400 0.121
201609 0.115 102.400 0.130
201612 0.104 102.600 0.117
201703 0.122 103.200 0.137
201706 0.134 103.100 0.150
201709 0.111 104.100 0.123
201712 0.100 104.500 0.111
201803 0.137 105.300 0.151
201806 0.128 104.900 0.141
201809 0.154 106.600 0.167
201812 0.109 106.500 0.119
201903 0.222 107.700 0.239
201906 0.182 107.700 0.196
201909 0.162 109.800 0.171
201912 0.127 111.200 0.132
202003 0.249 112.300 0.257
202006 0.279 110.400 0.293
202009 0.243 111.700 0.252
202012 0.174 111.500 0.181
202103 0.299 112.662 0.307
202106 0.268 111.769 0.278
202109 0.150 112.215 0.155
202112 -0.017 113.108 -0.017
202203 0.408 114.335 0.413
202206 0.342 114.558 0.346
202209 0.060 115.339 0.060
202212 0.100 115.116 0.101
202303 0.520 115.116 0.523
202306 0.290 114.558 0.293
202309 0.220 115.339 0.221
202312 0.000 114.781 0.000
202403 0.350 115.227 0.352
202406 0.230 114.781 0.232
202409 0.170 115.785 0.170

Add all the adjusted EPS together and divide 10 will get our e10.


DaShenLin Pharmaceutical Group Co  (SHSE:603233) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

DaShenLin Pharmaceutical Group Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=16.76/0.83
=20.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Shiller P/E Ratio of DaShenLin Pharmaceutical Group Co was 20.28. The lowest was 16.39. And the median was 18.43.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


DaShenLin Pharmaceutical Group Co E10 Related Terms

Thank you for viewing the detailed overview of DaShenLin Pharmaceutical Group Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


DaShenLin Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co Headlines

No Headlines